Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 3.68M
2: EX-21 Subsidiaries List HTML 205K
3: EX-23 Consent of Expert or Counsel HTML 41K
7: EX-97 Clawback Policy re: Recovery of Erroneously HTML 62K
Awarded Compensation
4: EX-31.1 Certification -- §302 - SOA'02 HTML 45K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 45K
6: EX-32 Certification -- §906 - SOA'02 HTML 42K
13: R1 Cover Page HTML 120K
14: R2 Audit Information HTML 46K
15: R3 Consolidated Statement of Income and Comprehensive HTML 153K
Income
16: R4 Consolidated Balance Sheet HTML 186K
17: R5 Consolidated Balance Sheet (Parenthetical) HTML 55K
18: R6 Consolidated Statement of Cash Flows HTML 166K
19: R7 Consolidated Statement of Shareholders Equity HTML 127K
20: R8 Consolidated Statement of Shareholders Equity HTML 48K
(Parenthetical)
21: R9 Nature of Operations and Summary of Significant HTML 123K
Accounting Policies
22: R10 Restructuring and Other Charges HTML 151K
23: R11 Acquisitions (Notes) HTML 64K
24: R12 Business Divestiture HTML 132K
25: R13 Property, Plant and Equipment, Net HTML 56K
26: R14 Goodwill and Other Intangible Assets, Net HTML 107K
27: R15 Other Assets And Liabilities, Current and HTML 79K
Noncurrent
28: R16 Debt HTML 126K
29: R17 Leases (Notes) HTML 104K
30: R18 Income Taxes HTML 144K
31: R19 Net Income Per Share HTML 66K
32: R20 Shareholders' Equity HTML 48K
33: R21 Stock Compensation Plans HTML 122K
34: R22 Segment Information HTML 160K
35: R23 Employee Benefits HTML 419K
36: R24 Financial Instruments HTML 160K
37: R25 Accumulated Other Comprehensive Income (Loss) HTML 111K
38: R26 Concentrations of Credit Risk HTML 44K
39: R27 Commitments and Contingencies HTML 73K
40: R28 Redeemable Noncontrolling Interests HTML 60K
41: R29 Assets and Liabilities Held For Sale HTML 132K
42: R30 Other Income and Expenses HTML 57K
43: R31 Tangible Equity Units HTML 48K
44: R32 Schedule II - Valuation and Qualifying Accounts HTML 79K
and Reserves
45: R33 Insider Trading Arrangements HTML 49K
46: R34 Nature of Operations and Summary of Significant HTML 164K
Accounting Policies (Policies)
47: R35 Nature of Operations and Summary of Significant HTML 78K
Accounting Policies (Tables)
48: R36 Restructuring and Other Charges (Tables) HTML 146K
49: R37 Acquisitions (Tables) HTML 56K
50: R38 Discontinued Operations and Disposal Groups HTML 123K
(Tables)
51: R39 Property, Plant and Equipment, Net (Tables) HTML 54K
52: R40 Goodwill and Other Intangible Assets, Net (Tables) HTML 108K
53: R41 Other Assets And Liabilities, Current and HTML 82K
Noncurrent (Tables)
54: R42 Debt (Tables) HTML 106K
55: R43 Leases (Tables) HTML 106K
56: R44 Income Taxes (Tables) HTML 143K
57: R45 Net Income Per Share (Tables) HTML 61K
58: R46 Stock Compensation Plans (Tables) HTML 130K
59: R47 Segment Information (Tables) HTML 155K
60: R48 Employee Benefits (Tables) HTML 428K
61: R49 Financial Instruments (Tables) HTML 157K
62: R50 Accumulated Other Comprehensive Income (Loss) HTML 114K
(Tables)
63: R51 Redeemable Noncontrolling Interests (Tables) HTML 59K
64: R52 Assets and Liabilities Held For Sale (Tables) HTML 123K
65: R53 Other (Expense) Income, Net (Tables) HTML 56K
66: R54 Nature of Operations and Summary of Significant HTML 208K
Accounting Policies - Additional Information
(Detail)
67: R55 Nature of Operations and Summary of Significant HTML 51K
Accounting Policies - Schedule of Inventory
(Detail)
68: R56 Restructuring and Other Charges - Additional HTML 114K
Information (Details)
69: R57 Restructuring and Other Charges - Movements in HTML 91K
Restructuring and Related Accruals (Detail)
70: R58 Acquisitions - Health Wright Products (Details) HTML 68K
71: R59 Acquisitions - Nutrition & Biosciences, Inc HTML 110K
(Details)
72: R60 Business Divestiture (Details) HTML 224K
73: R61 Property, Plant and Equipment, Net - Schedule of HTML 69K
Property, Plant and Equipment (Detail)
74: R62 Goodwill and Other Intangible Assets, Net - HTML 80K
Narrative (Details)
75: R63 Goodwill and Other Intangible Assets, Net - HTML 79K
Goodwill Rollforward (Details)
76: R64 Goodwill and Other Intangible Assets, Net - HTML 59K
Trademark and Other Intangible Assets (Detail)
77: R65 Goodwill and Other Intangible Assets, Net - HTML 56K
Amortization Expense (Detail)
78: R66 Other Assets And Liabilities, Current and HTML 71K
Noncurrent - Schedule of Other Assets (Detail)
79: R67 Other Assets And Liabilities, Current and HTML 74K
Noncurrent - Schedule of Other Current Liabilities
(Details)
80: R68 Debt - Components of Debt (Detail) HTML 163K
81: R69 Debt - Additional Information - Term Loan and HTML 178K
Senior Notes Assumed (Detail)
82: R70 Debt - Additional Information - Revolving Credit HTML 105K
Facility (Detail)
83: R71 Debt - Additional Information - Senior Unsecured HTML 103K
Notes (Detail)
84: R72 Debt - Additional Information - Commercial Paper HTML 86K
and Redemption Provisions (Detail)
85: R73 Debt - Schedule of Debt Maturities (Details) HTML 55K
86: R74 Leases (Details) HTML 57K
87: R75 Leases - Schedule of Lease Expense (Details) HTML 49K
88: R76 Leases - Cash Flow (Details) HTML 52K
89: R77 Leases - Balance Sheet (Details) HTML 63K
90: R78 Leases - Weighted Average (Details) HTML 50K
91: R79 Leases - Schedule of Lease Maturities (Details) HTML 97K
92: R80 Leases - Additional Information (Details) HTML 55K
93: R81 Income Taxes - Schedule of Earnings before Income HTML 51K
Taxes (Detail)
94: R82 Income Taxes - Schedule of Income Tax Provision HTML 69K
(Detail)
95: R83 Income Taxes - Reconciliation of Effective Income HTML 82K
Tax Rate (Details)
96: R84 Income Taxes - Schedule of Reconciliation between HTML 54K
U.S. Federal Statutory Income Tax Rate to Actual
Effective Tax Rate (Detail)
97: R85 Income Taxes - Additional Information (Detail) HTML 91K
98: R86 Income Taxes - Schedule of Deferred Tax Assets and HTML 75K
Liabilities (Detail)
99: R87 Income Taxes - Reconciliation of Beginning and HTML 67K
Ending Amount of Unrecognized Tax Benefits
(Detail)
100: R88 Net Income Per Share - Reconciliation of Shares HTML 71K
Used in Computation of Basic and Diluted Net
Income Per Share (Detail)
101: R89 Net Income Per Share - Additional Information HTML 64K
(Detail)
102: R90 Net Income Per Share - TEU (Details) HTML 52K
103: R91 Shareholders' Equity - Additional Information HTML 47K
(Detail)
104: R92 Stock Compensation Plans - Additional Information HTML 111K
(Detail)
105: R93 Stock Compensation Plans - Stock-Based HTML 60K
Compensation Expense Included in Consolidated
Statement of Income and Comprehensive Income
(Detail)
106: R94 Stock Compensation Plans - SSAR's and Stock Option HTML 64K
- Additional Information (Detail)
107: R95 Stock Compensation Plans - SSAR's and Stock Option HTML 72K
Activity (Detail)
108: R96 Stock Compensation Plans - SSAR's and Stock Option HTML 71K
Outstanding (Detail)
109: R97 Stock Compensation Plans - SSAR's and Stock Option HTML 61K
Exercisable (Detail)
110: R98 Stock Compensation Plans - Restricted Stock Units HTML 65K
Plan - Additional Information (Detail)
111: R99 Stock Compensation Plans - RSU, PRS and Cash RSU HTML 91K
Activity (Detail)
112: R100 Stock Compensation Plans - Purchased Restricted HTML 68K
Stock Plan - Additional Information (Detail)
113: R101 Stock Compensation Plans - Liability Awards - HTML 64K
Additional Information (Detail)
114: R102 Segment Information - Additional Information HTML 95K
(Detail)
115: R103 Segment Information - Reportable Segment HTML 113K
Information (Detail)
116: R104 Segment Information - Capital Expenditure and HTML 58K
Depreciation and Amortization by Segment (Detail)
117: R105 Segment Information - Net Sales by Geographic Area HTML 59K
(Detail)
118: R106 Segment Information Segment Information - Schedule HTML 59K
of Long Lived Assets (Details)
119: R107 Employee Benefits - Additional Information HTML 98K
(Detail)
120: R108 Employee Benefits - Plan Assets and Benefit HTML 91K
Obligations of Defined Benefit Pension Plans
(Detail)
121: R109 Employee Benefits - Components of Net Periodic HTML 67K
Benefit Cost and Changes in Plan Assets and
Benefit Obligations Recognized in OCI (Detail)
122: R110 Employee Benefits - Weighted-Average Actuarial HTML 54K
Assumption Used to Determine Expense (Detail)
123: R111 Employee Benefits - Changes in Postretirement HTML 116K
Benefit Obligation and Plan Assets (Detail)
124: R112 Employee Benefits - Amounts Recognized in Balance HTML 60K
Sheet (Detail)
125: R113 Employee Benefits - Amounts Recognized in HTML 57K
Accumulated Other Comprehensive Income (Detail)
126: R114 Employee Benefits - Accumulated Benefit Obligation HTML 66K
(Detail)
127: R115 Employee Benefits - Estimated Future Benefit HTML 66K
Payments (Detail)
128: R116 Employee Benefits - Percentage of Assets Invested HTML 62K
(Detail)
129: R117 Employee Benefits - Fair Value Hierarchy of Plan HTML 208K
Assets (Detail)
130: R118 Employee Benefits - Reconciliation of Level 3 HTML 65K
Non-U.S. Plan Assets Held (Detail)
131: R119 Employee Benefits - Weighted Average Assumptions HTML 51K
Used to Determine Postretirement Benefit Expense
and Obligation (Detail)
132: R120 Financial Instruments - Carrying Amount and HTML 125K
Estimated Fair Value of Financial Instruments
(Detail)
133: R121 Financial Instruments - Derivative Instruments HTML 50K
Notional Amount Outstanding (Detail)
134: R122 Financial Instruments - Derivative Instruments HTML 65K
Measured at Fair Value (Detail)
135: R123 Financial Instruments - Derivative Instruments HTML 54K
Which Were Not Designated as Hedging Instruments
(Detail)
136: R124 Financial Instruments - Derivative Instruments HTML 67K
Designated as Cash Flow and Net Investment Hedging
Instruments (Detail)
137: R125 Financial Instruments - Additional Information HTML 96K
(Detail)
138: R126 Accumulated Other Comprehensive Income (Loss) - HTML 74K
Schedule of Changes in Accumulated Other
Comprehensive Income (Loss) (Detail)
139: R127 Accumulated Other Comprehensive Income (Loss) - HTML 80K
Reclassifications of Accumulated Other
Comprehensive Income to Consolidated Statement of
Comprehensive Income (Detail)
140: R128 Concentrations Of Credit Risk - Additional HTML 50K
Information (Detail)
141: R129 Commitments and Contingencies - Additional HTML 130K
Information (Detail)
142: R130 Redeemable Noncontrolling Interests (Details) HTML 71K
143: R131 Assets and Liabilities Held For Sale (Details) HTML 91K
144: R132 Other (Expense) Income, Net (Details) HTML 57K
145: R133 Tangible Equity Units (Details) HTML 46K
146: R134 Tangible Equity Units (Allocation of TEU) HTML 42K
(Details)
147: R135 Tangible Equity Units Tangible Equity - Settlement HTML 50K
of Shares (Details)
148: R136 Schedule II - Valuation and Qualifying Accounts HTML 61K
and Reserves (Detail)
150: XML IDEA XML File -- Filing Summary XML 291K
153: XML XBRL Instance -- iff-20231231_htm XML 6.13M
149: EXCEL IDEA Workbook of Financial Report Info XLSX 389K
9: EX-101.CAL XBRL Calculations -- iff-20231231_cal XML 455K
10: EX-101.DEF XBRL Definitions -- iff-20231231_def XML 2.49M
11: EX-101.LAB XBRL Labels -- iff-20231231_lab XML 4.62M
12: EX-101.PRE XBRL Presentations -- iff-20231231_pre XML 3.28M
8: EX-101.SCH XBRL Schema -- iff-20231231 XSD 464K
151: JSON XBRL Instance as JSON Data -- MetaLinks 1,124± 1.74M
152: ZIP XBRL Zipped Folder -- 0000051253-24-000006-xbrl Zip 1.13M
1.I have reviewed this Annual Report on Form 10-K of International Flavors & Fragrances Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant
deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
